Divis Laboratories, a leading player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1990, the company has established itself as a prominent manufacturer of active pharmaceutical ingredients (APIs) and intermediates, catering to a global clientele. With a strong focus on research and development, Divis Laboratories has achieved significant milestones, including the successful launch of several high-quality products that meet stringent regulatory standards.
The company’s core offerings include APIs for various therapeutic areas, particularly in anti-retroviral and anti-cancer medications, which are distinguished by their purity and efficacy. Divis Laboratories is recognised for its robust market position, consistently ranking among the top suppliers in the industry. Its commitment to innovation and sustainability further enhances its reputation as a trusted partner in the pharmaceutical landscape.
+26 vs industry average
Divis Laboratories’s score of 55 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Divis Laboratories?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Divis Laboratories's reported carbon emissions
In 2025, Divis Laboratories, headquartered in India, reported total greenhouse gas emissions of approximately 1.6 billion kg CO2e. This total includes 339,941,000 kg CO2e from Scope 1, 357,810,000 kg CO2e from Scope 2, and 896,952,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to achieve net-zero emissions across its value chain by FY2050. Divis Laboratories has established near-term targets to reduce absolute Scope 1 and Scope 2 emissions by 58.8% by FY2034, using FY2024 as the baseline year. Additionally, the company aims to cut absolute Scope 3 emissions by 35% within the same timeframe. For the long term, the company has committed to a 90% reduction in absolute emissions across all scopes by FY2050, also from a FY2024 baseline. These targets align with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit warming to 1.5°C. The company is actively working towards these goals, demonstrating a strong commitment to sustainability and climate action in the pharmaceutical sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Divis Laboratories’s Climate Goals (2030 & 2050)
2 goals2030
25% reduction in Scope 1
Reduce intensity based GHG (Scope-1 & Scope-2) emission by 25%.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Divis Laboratories’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project